glutathione supplement liposomal Liposomal Glutathione for Immune Support

Phase Cag introduction Weeks 9-12 Retatrutide 4 mg/week (hold) Cagrilintide 0.25 mg/week Notes Add cagrilintide at the lowest dose

This product is supplied strictly as a research compound and is not intended for human or veterinary use

IV administration also introduces risks that oral supplementation does not: Contamination or excessive endotoxin exposure Sterility and compounding failures Infusion reactions Venous irritation or infection Dosing errors Additional cost and clinical complexity The FDA has reported adverse events among patients who received injectable compounded glutathione made with an unsuitable dietary ingredient

As someone familiar with formulation development, I know that serum products often require careful control over ingredient compatibility, delivery systems, and texture stability